You're using a free limited version of DrugPatentWatch: Upgrade for Complete Access

Last Updated: December 24, 2024

Details for Patent: 9,708,615


✉ Email this page to a colleague

« Back to Dashboard


Summary for Patent: 9,708,615
Title:Therapeutic compositions
Abstract: This application relates to therapeutic siRNA agents and methods of making and using the agents.
Inventor(s): Manoharan; Muthiah (Cambridge, MA), Rajeev; Kallanthottathil G. (Cambridge, MA), Bumcrot; David (Cambridge, MA)
Assignee: Alnylam Pharmaceuticals, Inc. (Cambridge, MA)
Application Number:14/943,612
Patent Claim Types:
see list of patent claims
Use;
Patent landscape, scope, and claims:

Analyzing the Scope and Claims of United States Patent 9,708,615

Introduction

United States Patent 9,708,615, titled "Therapeutic compositions," is a patent that relates to therapeutic siRNA (small interfering RNA) agents and methods for making and using these agents. This analysis will delve into the scope, claims, and the broader patent landscape surrounding this invention.

Patent Overview

Publication Number and Authority The patent in question is US9708615B2, issued by the United States Patent and Trademark Office (USPTO)[4].

Inventorship and Assignees

Determining True Inventors Inventorship is a critical aspect of patent law. According to US patent law, the true and only inventors must be listed on the patent application. This involves identifying those who conceived the idea and reduced it to practice[5].

Claims Analysis

Claim Structure The patent claims are the heart of any patent, defining the scope of the invention. For US9708615B2, the claims can be broadly categorized into several types:

Independent Claims

These claims stand alone and define the invention without reference to other claims. They typically describe the broadest scope of the invention.

Dependent Claims

These claims refer back to and further limit the independent claims. They often describe specific embodiments or variations of the invention.

Method Claims

These claims describe the methods of making and using the therapeutic siRNA agents.

Composition Claims

These claims describe the therapeutic compositions themselves, including the siRNA agents and any other components.

Scope of the Invention

Therapeutic siRNA Agents The patent covers therapeutic compositions comprising siRNA agents designed to target specific sequences. These agents are intended for the treatment of various diseases by silencing specific genes.

Target Sequences

The patent specifies the sequences that the siRNA agents are designed to target. This is crucial as it defines the scope of the therapeutic application.

Methods of Use

The methods of using these therapeutic compositions are also claimed, including administration routes and dosages.

Prior Art and Citation Data

Common Citation Document (CCD) To understand the prior art landscape, tools like the Common Citation Document (CCD) can be used. The CCD consolidates citation data from multiple patent offices, providing a single point of access to prior art cited by all participating offices for the family members of a patent application[1].

Patent Family and Global Dossier

Global Dossier The Global Dossier service allows users to view the patent family for a specific application, including all related applications filed at participating IP Offices. This can help in understanding the global scope and status of the patent[1].

Legal Status and Enforcement

Validity and Enforceability The patent's legal status is crucial for its enforcement. Any deceptive intent in naming inventors or errors in inventorship can render the patent unenforceable. Ensuring correct inventorship is vital to maintain the patent's validity[5].

Economic and Research Implications

Patent Claims Research Dataset The USPTO's Patent Claims Research Dataset provides detailed information on claims from US patents and applications. This dataset can be used to analyze trends and statistics related to patent scope and claims, offering insights into the economic and research implications of patents like US9708615B2[3].

Public Access and Search Tools

USPTO Public Search Facility and PTRCs For further research, the USPTO Public Search Facility and Patent and Trademark Resource Centers (PTRCs) offer extensive resources and trained staff to assist in patent searches and analysis[1].

Sequence Listings and Mega Items

Publication Site for Issued and Published Sequences (PSIPS) For patents involving sequences, such as US9708615B2, the PSIPS website provides access to sequence listings, tables, and other mega items for granted US patents or published US patent applications[1].

Assignment and Ownership

Patent Assignment Search Changes in ownership or assignments of the patent can be tracked using the Patent Assignment Search website, which is essential for understanding the current status and ownership of the patent[1].

Key Takeaways

  • Inventorship: Correct identification of inventors is crucial for the validity and enforceability of the patent.
  • Claims Analysis: Understanding the structure and scope of claims is essential for defining the invention.
  • Prior Art: Tools like the CCD help in understanding the prior art landscape.
  • Global Dossier: This service provides a comprehensive view of the patent family and related applications.
  • Legal Status: Ensuring the patent's legal status is vital for its enforcement.
  • Public Access: Utilizing USPTO resources and PTRCs can facilitate detailed patent searches and analysis.

FAQs

Q: What is the main subject matter of US Patent 9,708,615? A: The main subject matter is therapeutic siRNA agents and methods for making and using these agents.

Q: How important is correct inventorship in patent applications? A: Correct inventorship is crucial as errors or deceptive intent can render the patent unenforceable.

Q: What is the Global Dossier service, and how does it help? A: The Global Dossier service provides access to the file histories of related applications from participating IP Offices, helping users understand the global scope and status of the patent.

Q: Where can I find detailed information on claims from US patents? A: The USPTO's Patent Claims Research Dataset provides detailed information on claims from US patents and applications.

Q: How can I track changes in ownership of a patent? A: The Patent Assignment Search website allows users to search for patent assignments and changes in ownership.

Sources

  1. USPTO - Search for patents: https://www.uspto.gov/patents/search
  2. USA.gov - U.S. Patent and Trademark Office (USPTO): https://www.usa.gov/agencies/u-s-patent-and-trademark-office
  3. USPTO - Patent Claims Research Dataset: https://www.uspto.gov/ip-policy/economic-research/research-datasets/patent-claims-research-dataset
  4. Google Patents - US9708615B2: https://patents.google.com/patent/US9708615B2/en
  5. Oregon State University - Determining Inventorship for US Patent Applications: https://agsci.oregonstate.edu/sites/agsci/files/main/research/vrc_release_inventorship-gattari.pdf

More… ↓

⤷  Subscribe


Drugs Protected by US Patent 9,708,615

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Patented / Exclusive Use Submissiondate
Alnylam Pharms Inc GIVLAARI givosiran sodium SOLUTION;SUBCUTANEOUS 212194-001 Nov 20, 2019 RX Yes Yes ⤷  Subscribe ⤷  Subscribe Y ⤷  Subscribe
Novartis LEQVIO inclisiran sodium SOLUTION;SUBCUTANEOUS 214012-001 Dec 22, 2021 RX Yes Yes ⤷  Subscribe ⤷  Subscribe Y ⤷  Subscribe
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Patented / Exclusive Use >Submissiondate

International Family Members for US Patent 9,708,615

Country Patent Number Estimated Expiration Supplementary Protection Certificate SPC Country SPC Expiration
Austria 479752 ⤷  Subscribe
Australia 2004220556 ⤷  Subscribe
Australia 2004227414 ⤷  Subscribe
Australia 2004229519 ⤷  Subscribe
Australia 2004232964 ⤷  Subscribe
Australia 2004233092 ⤷  Subscribe
>Country >Patent Number >Estimated Expiration >Supplementary Protection Certificate >SPC Country >SPC Expiration

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.